tocophersolan has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, Q; Kong, L; Qin, X; Tu, J; Tu, K; Wang, L; Xu, H; Yuan, X; Zhang, Z | 1 |
| Adams, DJ; Barui, AK; Kulhari, H; Naidu Vegi, GM; Patra, CR; Pooja, D; Shrivastava, S; Sistla, R; Telukutala, SR | 1 |
2 other study(ies) available for tocophersolan and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy.
Topics: Animals; Apoptosis; Carcinoma, Lewis Lung; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred C57BL; Micelles; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Donors; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Hypoxia; Vitamin E | 2020 |
Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Docetaxel; Human Umbilical Vein Endothelial Cells; Humans; Integrins; Male; Micelles; Nanostructures; Neovascularization, Pathologic; Peptides, Cyclic; Polyethylene Glycols; Prostatic Neoplasms; Receptors, Cell Surface; Taxoids; Vitamin E | 2015 |